Because EBL is a bovine hematological malignancy, bta-miR-1246 may also suppress tumor suppressor genes, such as DENND2D, and may promote the progression of EBL, and could be a candidate biomarker for the development of EBL. Here, DENND2D is linked to neoplasm.